Top Markets
Coin of the day
InDex Pharmaceuticals Holding AB (publ) InDex Pharmaceuticals Holding AB (publ)

InDex Pharmaceuticals Holding AB (publ)

INDEX
Peringkat dalam Saham #28996
InDex Pharmaceuticals Holding AB (publ) is a pharmaceutical firm dedicated to... InDex Pharmaceuticals Holding AB (publ) is a pharmaceutical firm dedicated to developing therapeutic solutions for patients affected by ulcerative colitis. The company's flagship drug candidate, Cobitolimod, is presently in Phase III clinical trials, targeting the treatment of moderate to severe ulcerative colitis. Furthermore, InDex is progressing a pipeline of other DNA-based immunomodulatory sequences, which are in the preclinical phase, designed to address various immunological conditions. This enterprise was established in 2000 and operates from its headquarters in Solna, Sweden.
Harga Saham
$0.04406501
Terakhir disinkronkan: 2024-07-09
Kapitalisasi Pasar
$23.47M
Perubahan (1 hari)
-0.48%
Perubahan (1 tahun)
0.00%
Negara
SE
Perdagangan InDex Pharmaceuticals Holding AB (publ) (INDEX)

Kategori

Riwayat hasil dividen untuk InDex Pharmaceuticals Holding AB (publ) (INDEX)
Hasil dividen (TTM) dari InDex Pharmaceuticals Holding AB (publ) (simbol saham: INDEX) per 2026: 0
Rata-rata hasil dividen selama 5 tahun terakhir: 0.00%
Riwayat hasil dividen untuk InDex Pharmaceuticals Holding AB (publ) (INDEX) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Hasil dividen (TTM) untuk perusahaan serupa atau pesaing
Perusahaan Hasil Dividen Negara
0.00%
US
0.00%
NL
0.00%
US
3.12%
AU
0.00%
CH